chronic constipation
Gastroenterology · 2007–2011
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| prucalopride Treatment of moderate to severe chronic functional constipation in adults who are intolerant to or not adequately controlled with both bulk forming agents and… | Nov 2011 | Not recommended | no section in document |
| macrogol 3350 plus electrolytes Chronic constipation or faecal impaction not adequately controlled with first-line interventions such as bulk-forming agents; also for constipation in patients… | Nov 2007 | Recommended with restriction | no section in document |
| macrogol 3350 plus electrolytes Chronic constipation or faecal impaction not adequately controlled with first-line interventions such as bulk-forming agents; also for constipation in patients… | Nov 2007 | Recommended with restriction | no section in document |
What the PBS pays
$50M in government benefit over 2024–25, across 2,879,974 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| macrogol 3350 | $24.9M |
| macrogol 3350 plus electrolytes | $24.9M |
Appraised elsewhere
NICE, in England and Wales, has appraised 1 technology for this condition, recommending 1 . A different committee, a different population and a different price: this is what has been looked at there, not a verdict on what happened here.
| Technology | Appraisal | Outcome | Date |
|---|---|---|---|
| prucalopridePrucalopride for the treatment of chronic constipation in women | TA211 | recommended restricted | 2010-12 |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.